Human Genome Research in North Carolina
Human Genome Research (93.172) awarded $119 million to recipients in North Carolina in 59 grants from fiscal 2021 to 2025, 5.5% of the program's national total. University of North Carolina at Chapel Hill received the most, $55.8 million.
- Awarded in North Carolina$119 million
- Awards59
- Share of the program5.5%
- Rank among states5th of 45
- National total$2.2 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 26 | $19.7 million |
| FY 2022 | 32 | $27.7 million |
| FY 2023 | 33 | $27.9 million |
| FY 2024 | 29 | $25.0 million |
| FY 2025 | 23 | $19.1 million |
Recipients in North Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of North Carolina at Chapel Hill | Colleges and universities | 20 | $55.8 million |
| Duke University | Colleges and universities | 21 | $45.6 million |
| Epicypher, Inc. | Small businesses | 6 | $8.2 million |
| Research Triangle Institute | Nonprofits | 4 | $5.2 million |
| North Carolina Agricultural and Technical State University | Colleges and universities | 1 | $2.5 million |
| Wake Forest University Health Sciences | Colleges and universities | 1 | $742,710 |
| University of North Carolina at Charlotte | Colleges and universities | 1 | $554,230 |
| Enfuego Therapeutics, Inc. | Small businesses | 1 | $275,645 |
| Martingale Labs, Inc. | Small businesses | 1 | $186,469 |
| International Mammalian Genome Society, Inc | Nonprofits | 1 | $177,120 |
Open opportunities under this program
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
See all 65 on the program page
Questions people ask
How much Human Genome Research money goes to North Carolina?
$119 million from fiscal 2021 to 2025, across 59 awards. North Carolina ranks 5th of 45 states and territories for this program.
Who receives Human Genome Research money in North Carolina?
The largest recipient is University of North Carolina at Chapel Hill, with $55.8 million in 20 awards. Next are Duke University and Epicypher, Inc..
Can organizations in North Carolina apply now?
Yes, 65 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Human Genome Research in other states
Other large programs in North Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- USAID Foreign Assistance for Programs Overseas
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States